This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07137/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07137/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07137/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07137/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07137/identifier/chemspider/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07137
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n12:DB07137 n13:DB07137
dcterms:title
(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE
adms:identifier
n4:529 n7:7875343 n8:9601217 n9:99443608 n14:DB07137
n5:IUPAC-Name
n6:271B4D8F-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4D95-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4D94-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4D91-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4D92-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4D93-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4D8D-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4D8B-363D-11E5-9242-09173F13E4C5 n6:271B4D8E-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4D8C-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4D9B-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4D9C-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4D96-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4D97-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4D99-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4D98-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4D9A-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4DA1-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4DA3-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4DA4-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4DA0-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4D9F-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4DA2-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4D90-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4D9D-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4D9E-363D-11E5-9242-09173F13E4C5